| Ytd | 18.72% | |
| 1y | 5.16% |
| Open | 389.90 | Prev Close | 386.73 | Low | 389.56 | High | 416.23 | Mkt Cap | 90.38B |
| Vol | 1.56M | Avg Vol | 1.74M | EPS | 23.60 | P/E | 17.64 | Forward P/E | 13.24 |
| Beta | 0.68 | Short Ratio | 3.75 | Inst. Own | 93.91% | Dividend | 6.88 | Div Yield | 1.77 |
| Ex Div Date | 06-10 | Earning | 07-16 | 50-d Avg | 387.00 | 200-d Avg | 344.43 | 1yr Est | 418.67 |
Carelon is becoming a major growth driver for ELV, boosting revenues, care efficiency and long-term
INDIANAPOLIS--(BUSINESS WIRE)--The No Surprises Act was created to protect patients from unexpected
CNSide Diagnostics, LLC, a wholly-owned subsidiary of Plus Therapeutics, Inc. (Nasdaq: PSTV) ("P
Elevance Health (NYSE:ELV) today announced it has invested $640 million in affordable housing over t
Elevance Health (NYSE:ELV) expects FY2026 GAAP EPS of at least $19.85 per share; Reaffirms Adj EPS o
Mizuho analyst Ann Hynes maintains Elevance Health (NYSE:ELV) with a Outperform and raises the pr
B of A Securities analyst Kevin Fischbeck maintains Elevance Health (NYSE:ELV) with a Buy and rai
Morgan Stanley analyst Erin Wright maintains Elevance Health (NYSE:ELV) with a Equal-Weight and r
Truist Securities analyst David Macdonald maintains Elevance Health (NYSE:ELV) with a Buy and rai